Modified methylenedioxyphenol analogs lower LDL cholesterol through induction of LDL receptor expression
Although statin therapy is a cornerstone of current low density lipoprotein (LDL)-lowering strategies, there is a need for additional therapies to incrementally lower plasma LDL cholesterol. In this study, we investigated the effect of several methylenedioxyphenol derivatives in regulating LDL chole...
Main Authors: | Zhekang Ying, Rajagopal Desikan, Xiaohua Xu, Andrei Maiseyeu, Cuiqing Liu, Qinghua Sun, Ouiliana Ziouzenkova, Sampath Parthasarathy, Sanjay Rajagopalan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-05-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752039218X |
Similar Items
-
Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice
by: Masa-aki Kawashiri, et al.
Published: (2001-06-01) -
Asociation of PCSK9 with Low Density Lipoproteins (LDL) in the Regulation of LDL-Cholesterol Levels
by: Sarkar, Samantha Khadija
Published: (2015) -
Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC
by: Jun Dong, et al.
Published: (2011-02-01) -
A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo1[S]
by: Yan G. Ni, et al.
Published: (2011-01-01) -
Metabolic origins and clinical significance of LDL heterogeneity
by: Kaspar K. Berneis, et al.
Published: (2002-09-01)